These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25175960)

  • 21. An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers.
    Brooks DJ; Papapetropoulos S; Vandenhende F; Tomic D; He P; Coppell A; O'Neill G
    Clin Neuropharmacol; 2010; 33(2):55-60. PubMed ID: 20375654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of [11C]FR194921 as a nonxanthine-type PET tracer for adenosine A1 receptors in the brain.
    Matsuya T; Takamatsu H; Murakami Y; Noda A; Ichise R; Awaga Y; Nishimura S
    Nucl Med Biol; 2005 Nov; 32(8):837-44. PubMed ID: 16253808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoids regulate the expression of adenosine A1 but not A(2A) receptors in rat brain.
    Svenningsson P; Fredholm BB
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1094-101. PubMed ID: 9023328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivatives of 4,6-diamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-2H-1-one: potential antagonist ligands for imaging the A2A adenosine receptor by positron emission tomography (PET).
    Holschbach MH; Bier D; Wutz W; Sihver W; Schüller M; Olsson RA
    Eur J Med Chem; 2005 May; 40(5):421-37. PubMed ID: 15893016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
    J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.
    van der Wenden EM; Carnielli M; Roelen HC; Lorenzen A; von Frijtag Drabbe Künzel JK; IJzerman AP
    J Med Chem; 1998 Jan; 41(1):102-8. PubMed ID: 9438026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine receptors and Huntington's disease.
    Lee CF; Chern Y
    Int Rev Neurobiol; 2014; 119():195-232. PubMed ID: 25175968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine A1 receptor mapping of the human brain by PET with 8-dicyclopropylmethyl-1-11C-methyl-3-propylxanthine.
    Fukumitsu N; Ishii K; Kimura Y; Oda K; Sasaki T; Mori Y; Ishiwata K
    J Nucl Med; 2005 Jan; 46(1):32-7. PubMed ID: 15632030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET.
    Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K
    J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.
    Dalpiaz A; Gessi S; Varani K; Borea PA
    Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The [18F]-FNECA serves as a suitable radioligand for PET investigation of purinergic receptor expression].
    Márián T; Lehel S; Lengyel Z; Balkay L; Horváth G; Mikecz P; Miklovicz T; Fekete I; Szentmiklósi AJ
    Orv Hetil; 2002 May; 143(21 Suppl 3):1319-22. PubMed ID: 12077928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of 7-amino-2-(2(3)-furyl)-5-phenylethylamino-oxazolo[5,4-d]pyrimidines as potential A2A adenosine receptor antagonists for positron emission tomography (PET).
    Holschbach MH; Bier D; Stüsgen S; Wutz W; Sihver W; Coenen HH; Olsson RA
    Eur J Med Chem; 2006 Jan; 41(1):7-15. PubMed ID: 16289482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A PET study of adenosine A1 receptor in anesthetized monkey brain.
    Wakabayashi S; Nariai T; Ishiwata K; Nagaoka T; Hirakawa K; Oda K; Sakiyama Y; Shumiya S; Toyama H; Suzuki F; Senda M
    Nucl Med Biol; 2000 May; 27(4):401-6. PubMed ID: 10938476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography for brain research.
    Mishina M
    J Nippon Med Sch; 2008 Apr; 75(2):68-76. PubMed ID: 18475026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The adenosine neuromodulation system in schizophrenia.
    Rial D; Lara DR; Cunha RA
    Int Rev Neurobiol; 2014; 119():395-449. PubMed ID: 25175974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Goalpha in human brain.
    Kudlacek O; Waldhoer M; Kassack MU; Nickel P; Salmi JI; Freissmuth M; Nanoff C
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):8-16. PubMed ID: 11862328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
    Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
    J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of novel 1,3,8- and 1,3,7,8-substituted xanthines as adenosine receptor antagonists.
    Rodríguez-Borges JE; García-Mera X; Balo MC; Brea J; Caamaño O; Fernández F; López C; Loza MI; Nieto MI
    Bioorg Med Chem; 2010 Mar; 18(5):2001-9. PubMed ID: 20137957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine receptor control of cognition in normal and disease.
    Chen JF
    Int Rev Neurobiol; 2014; 119():257-307. PubMed ID: 25175970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.